Enhancing neuro-oncology care through equity-driven applications of artificial intelligence
Neuro-Oncology · 2024
DOI: 10.1093/neuonc/noae127 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Neuro-Oncology, 2024. Verfasst von Mulki Mehari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Brain Neoplasms, Medical Oncology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The disease course and clinical outcome for brain tumor patients depend not only on the molecular and histological features of the tumor but also on the patient’s demographics and social determinants of health. While current investigations in neuro-oncology have broadly utilized artificial intelligence (AI) to enrich tumor diagnosis and more accurately predict treatment response, postoperative complications, and survival, equity-driven applications of AI have been limited. However, AI applications to advance health equity in the broader medical field have the potential to serve as practical blueprints to address known disparities in neuro-oncologic care. In this consensus review, we will describe current applications of AI in neuro-oncology, postulate viable AI solutions for the most pressing inequities in neuro-oncology based on broader literature, propose a framework for the effective integration of equity into AI-based neuro-oncology research, and close with the limitations of AI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.
- Division of Neuro-Oncology, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.
- Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurology, Memorial Sloan Kettering Cancer Center, Department of Neurology, Weill Cornell Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, New York, USA.
- Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Division of Neuro-Oncology, Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
ORCID-Profile: Annette M Molinaro, Joshua A Budhu, Sadhana Jackson, Alyx Porter, Shawn L Hervey-Jumper
Förderung
- NINDS NIH HHS
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Mehari, M., Sibih, Y., Dada, A., Chang, S. M., Wen, P. Y., Molinaro, A. M., Chukwueke, U. N., Budhu, J. A., Jackson, S., McFaline-Figueroa, J. R., Porter, A., & Hervey-Jumper, S. L. (2024). Enhancing neuro-oncology care through equity-driven applications of artificial intelligence. Neuro-Oncology. https://doi.org/10.1093/neuonc/noae127
Vancouver
Mehari M, Sibih Y, Dada A, Chang SM, Wen PY, Molinaro AM, et al. Enhancing neuro-oncology care through equity-driven applications of artificial intelligence. Neuro-Oncology. 2024. doi:10.1093/neuonc/noae127
BibTeX
@article{Mehari2024,
author = {Mehari, Mulki and Sibih, Youssef and Dada, Abraham and Chang, Susan M and Wen, Patrick Y and Molinaro, Annette M and Chukwueke, Ugonma N and Budhu, Joshua A and Jackson, Sadhana and McFaline-Figueroa, J Ricardo and Porter, Alyx and Hervey-Jumper, Shawn L},
title = {Enhancing neuro-oncology care through equity-driven applications of artificial intelligence},
journal = {Neuro-Oncology},
year = {2024},
doi = {10.1093/neuonc/noae127}
}
EUVIMED